The trademark application AD04 was filed by ADvantage Therapeutics GmbH, a corporation established under the laws of the Republic of Austria (the "Applicant"). The application was published for oppositions on July 25, 2022, and it was registered by office on November 1, 2022 without any oppositions.
It was designated 'Basic Application' for International Application 1707932 at the World Intellectual Property Organization (WIPO).
The application was filed in English (German was selected as the second language).
Change of name and professional address of the trademark registration was recorded on October 3, 2023.